You are here

Eric Williams

  • Managing Director
215-854-4065
(add to contacts)

Biography

Based out of Philadelphia, Eric serves as a Managing Director at Capstone Headwaters and leads Capstone’s Health and Medical practice. Eric has successfully completed more than 100 transactions in sectors including contract manufacturing, pharmaceutical outsourcing, medical devices, and life sciences, and health care services. Prior to Capstone, Eric was responsible for managing the Eastern region for Morgan Stanley Smith Barney’s Capital Strategies Group and its predecessor, Citi Capital Strategies.  Eric has 20 years of experience managing strategic sale assignments and leveraged recapitalizations for owners of privately held companies.

He has also executed complex cross-border transactions with foreign buyers based in London, Germany, Sweden and Switzerland and has structured deals with leading private equity groups and strategic corporate buyers.  Previously, Mr. Williams worked as a senior executive with Newport Securities Corporation.

Education

The University of California - BS - Economics

Registrations & Affiliations

FINRA - Series 24 General Securities Principal

FINRA - Series 7 & 63 Registered General Securities Representative

Industry Coverage

Merger and acquisition (M&A) activity has been strong in the industry both domestically and internationally, as buyers seek to consolidate the market and become premium cross-border education service providers. Notably, both Chinese company Bright Scholar Education Holdings Limited (NYSE:BEDU) and U.K.-based Busy Bees Childcare Limited expanded into new geographic territories this year including the U.S. Read more

The fundamentals in the Pharmaceutical Outsourcing industry remain solid as the sector continues to benefit from a record number of drugs under development and a rise in research and development initiatives targeting rare diseases.Read more

The Medical Device Outsourcing industry’s strong growth prospects and favorable fundamentals and demographic trends, coupled with the glut of private equity dry powder, is spurring deal activity from financial buyers.Read more